Get 20% lifetime commission for referring investors to digrin.com
here.
Protalix BioTherapeutics, Inc. ( PLX) - Key Metrics
PLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.25 | $0.05 | -$0.13 | -$0.14 |
| 2026Q1 | $0.42 | $0.23 | $0.28 | $0.27 |
| 2025Q4 | $0.12 | -$0.07 | $0.03 | $0.02 |
| 2025Q3 | $0.23 | $0.03 | -$0.05 | -$0.05 |
| 2025Q2 | $0.20 | $0 | -$0.07 | -$0.07 |
PLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 11.65 |
| 2026Q1 | 0% | 2.36 |
| 2025Q4 | 0% | -6.52 |
| 2025Q3 | 0% | 18.50 |
| 2025Q2 | 0% | 176.19 |
PLX
Price: $2.62
52 week price:
Earnings Per Share: 0.23 USD
P/E Ratio: 10.17
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 637200
Market Capitalization: 220.0 million